Pharmacogenomics Knowledgebase
Search PharmGKB |
About PharmGKB
The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships. PharmGKB collects, curates and disseminates knowledge about the impact of human genetic variation on drug responses through the following activities:
- Annotate genetic variants and gene-drug-disease relationships via literature reviews
- Summarize important pharmacogenomic genes, associations between genetic variants and drugs, and drug pathways
- Curate FDA , EMA, PMDA, and HCSC drug labels containing pharmacogenomic information
- Enable consortia examining important questions in pharmacogenomics
- Curate and participate in writing pharmacogenomic-based drug dosing guidelines
- Contribute to clinical implementation projects for pharmacogenomics through collaborations
- Publish pharmacogenomic-based drug dosing guidelines, very important pharmacogene summaries and drug-centered pathways
- Display all information on the website and provide comprehensive downloads
Contact
|
Teri E. Klein, PhD
CoPI & Director, PharmGKB CoPI, CPIC Tel: (650) 736-0156 Fax: (650) 725-3863 teri.klein@stanford.edu |
Russ B. Altman, MD PhD
The Kenneth Fong Professor of Engineering Professor, Bioengineering, Genetics, & Medicine CoPI PharmGKB Tel: (650) 725-3394 Fax: (650) 725-3863 russ.altman@stanford.edu |
Tiffany Murray
Genetics & Medicine Shriram Center ph: 650.725.0659 fax: 650.725.3863 tiffany.murray@stanford.edu |
Type of Award: R24
Grant Number: 1 R24 GM061374-16
Grant Number: 1 R24 GM061374-16
